Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

COX-2 inhibitors compared and contrasted.

A Bennett1, I A Tavares

  • 1Academic Department of Surgery, The Rayne Institute, Guy's, King's and St Thomas' Medical School, King's College, London, SE5 9NU, UK.

Expert Opinion on Pharmacotherapy
|February 5, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interferon-tau concentration at the vaginal fornix and cervical ostium predicted early pregnancy outcomes in lactating dairy cows†.

Biology of reproduction·2025
Same author

Prevalence, incidence, and progression of hip osteoarthritis in a young military population: The ADVANCE cohort study.

Osteoarthritis and cartilage open·2025
Same author

Evaluation of the current use of MRI to aid the diagnosis of axial spondyloarthritis in the UK: results from a freedom of information request.

Clinical radiology·2023
Same author

Photon spectra in NPL standard monoenergetic neutron fields.

Radiation protection dosimetry·2023
Same author

Development, design and experience of the UK Military's return to diving pathway following SARS-CoV-2 infection.

BMJ military health·2022
Same author

A balancing act: changing the referral pathway following remote consultations for dizziness during the coronavirus disease 2019 pandemic.

The Journal of laryngology and otology·2022

Non-steroidal anti-inflammatory drugs (NSAIDs) primarily treat pain and inflammation by inhibiting prostaglandin synthesis. Selective COX-2 inhibitors, like celecoxib, offer improved gastric safety compared to traditional NSAIDs, with older drugs also showing promise.

Area of Science:

  • Pharmacology
  • Drug Discovery
  • Medicinal Chemistry

Background:

  • Non-steroidal anti-inflammatory drugs (NSAIDs) are primary treatments for inflammation, pain, and fever.
  • NSAIDs inhibit prostaglandin (PG) synthesis, but this mechanism can lead to adverse events (AEs).
  • The discovery of COX-1 and COX-2 enzymes highlighted the potential for improved gastric safety by sparing COX-1.

Purpose of the Study:

  • To compare the efficacy, actions, and safety profiles of selective COX-2 inhibitors and older COX-1-sparing NSAIDs.
  • To analyze the therapeutic benefits and gastrointestinal (GI) safety of celecoxib, rofecoxib, etodolac, nimesulide, and meloxicam.
  • To discuss the similarities and differences among these five NSAID compounds.

Main Methods:

  • Comparative analysis of existing pharmacological data.

Related Experiment Videos

  • Review of clinical efficacy and safety studies.
  • Discussion of drug mechanisms of action, focusing on COX enzyme inhibition.

    • Main Results:

    • Selective COX-2 inhibitors (celecoxib, rofecoxib) demonstrate significant sales growth due to perceived safety benefits.
    • Older NSAIDs (etodolac, nimesulide, meloxicam), developed before COX-2 discovery, also exhibit COX-1 sparing properties.
    • These older agents possess good gastrointestinal safety and therapeutic efficacy.

    Conclusions:

    • Both newer selective COX-2 inhibitors and older COX-1-sparing NSAIDs offer therapeutic benefits with improved GI safety.
    • Understanding the nuances between these drug classes is crucial for optimizing pain and inflammation management.
    • Further comparative studies can refine the selection of NSAIDs based on individual patient needs and safety considerations.